Stroke in Covid-19 Patients: A Scoping Review

Abstract

Objective: to map the scientific production on patients infected by COVID-19 and the occurrence of stroke. Method: a scoping review, according to the framework proposed by the Joanna Briggs Institute, using the LILACS, MEDLINE, WoS, EMBASE, CINAHL and SCOPUS databases, from April to September 2020. The following keywords were used: coronavirus infections, stroke, nervous system diseases and inpatients, based on the Medical Subject Headings. Results: 24 studies that evidenced specific clinical symptoms of stroke such as dysarthria, facial paralysis, sensory deficit, headache, hemiparesis and ataxia in patients with COVID-19 were included. The association between stroke and COVID-19 was found by the following exams: C-reactive protein, D-dimer, computed tomography and, magnetic resonance, among others, as well as by care procedures focused on the findings in the exams, associated with three clinical outcomes, based on the brain ischemia zone affected and the time of viral manifestation of each patient. Conclusion: the specific clinical manifestations of patients who suffered a stroke after COVID-19 were mapped, as well as diagnostic procedures and therapies used, in addition to identifying neurological damage based on the clinical outcome of these patients.

Nursing theories in the care of stroke patients: a scoping review

“…Stroke is a prominent event in the epidemiological landscape, reinforcing the need for timely nursing care, whether in the acute phase of the disease or during rehabilitation, focused on prevention and control of complications ( 26 ) . Such care is also directed towards managing the hospital environment and organizing the healthcare team ( 27 ) , as this set of actions addresses a substantial portion of patient demands.…”

Relações clínicas da síndrome pós-COVID-19 com a síndrome pós-cuidados intensivos: uma revisão de escopo

“…In March 2020, the World Health Organization (WHO) declared a pandemic due to the worldwide spread of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), responsible for the contamination of more than 229 million people worldwide, from which more than 4.7 million evolved to death, and thousands more needed hospital care in Intensive Care Units (ICUs), due to the need for advanced health support and care from specialized professionals, which are organized according to age group care age in adult, pediatric and neonatal ICUs (1) . During hospitalization in the adult ICU, several patients who needed specialized care presented complications related to the viral disease, such as: prolonged and disseminated hypercoagulation, psychomotor and disabling factors related to cerebrovascular accidents (CVA) (2) , acute and chronic kidney disease, Acute Coronary Syndrome and myocardial infarction and severe hypoxia (3,4) . In addition to complications resulting from the ICU hospitalization, there are more than 50 symptoms that may arise after discharge related to SARS-CoV-2 infection, including: fatigue, dyspnea, cough, muscle dysfunction, joint pain, How to cite: Costa lack of cardiorespiratory conditioning, postural instability, chronic headache, tachycardia and chest pain (5,6) .…”